At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Immunoglobulin G detectionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Immunity Against the COVID-19 Vaccine in Healthcare Workers of Buenos Aires, Argentine.
In Brief
An observational study evaluating Immunoglobulin G detection for Coronavirus 2019 and 2 related conditions. Completed, enrolled 100 participants across 1 site.
Detailed Summary
Vaccination against coronavirus disease 19 (COVID-19) is an essential primary prevention tool to limit the health and economic effects of the pandemic. Objectives: To determine the variation in the levels of Immunoglobulin G (IgG) antibodies in health workers who received a COVID-19 vaccine.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronavirus 2019, Healthcare Workers, Vaccine
CountriesArgentina
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartApr 2021
First PostedApr 2021
Primary CompletionJun 2023
Study CompletionAug 2023
TodayJul 2026
First PostedApr 14, 2021
Enrollment StartApr 9, 2021
Primary CompletionJun 9, 2023
Study CompletionAug 9, 2023
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 5.2 years ago
Interventions
Immunoglobulin G detectionother
Detection of immunoglobulin G against Spike Receptor Binding Domain against severe acute respiratory syndrome coronavirus 2